MedChemComm p. 963 - 968 (2018)
Update date:2022-08-02
Topics:
Pippione, Agnese C.
Sainas, Stefano
Federico, Antonella
Lupino, Elisa
Piccinini, Marco
Kubbutat, Michael
Contreras, Jean-Marie
Morice, Christophe
Barge, Alessandro
Ducime, Alex
Boschi, Donatella
Al-Karadaghi, Salam
Lolli, Marco L.
NF-κB-inducing kinase (NIK), an oncogenic drug target that is associated with various cancers, is a central signalling component of the non-canonical pathway. A blind screening process, which established that amino pyrazole related scaffolds have an effect on IKKbeta, led to a hit-to-lead optimization process that identified the aminopyrazole 3a as a low μM selective NIK inhibitor. Compound 3a effectively inhibited the NIK-dependent activation of the NF-κB pathway in tumour cells, confirming its selective inhibitory profile.
View MoreShijiazhuang Frontierchem Co., Ltd.
Contact:+86-311-89271196
Address:4-4-202 No.15 Biandian Street,Shijiazhuang
Wuhan Chemwish Technology Co., Ltd
website:http://www.chemwish.com/
Contact:+86-27-67849912
Address:Room 1311, Unit 2, Block1, Innovation Road East Lake High-tech Development Zone Wuhan, Hubei,P.R. China
Zhushan County Tianxin Pharmaceutical & Chemical Co., Ltd.
Contact:0086-719-4224892
Address:Tutang Road, Chengguan Town, Zhushan County, Hubei Province
Yantai Derun Liquid Crystal Materials Co. Ltd.
website:http://www.ytderun.com
Contact:86-535-6300169
Address:ROOM 90, XIANGFU STREET, FUSHAN NEW-HIGH-TECH IDUSTRY ZONE, YANTAI
Contact:86-571-61063068
Address:LINAN
Doi:10.1021/ja01513a058
(1959)Doi:10.1016/j.poly.2004.06.014
(2004)Doi:10.1007/s11094-020-02172-4
(2020)Doi:10.1021/ja00395a071
(1981)Doi:10.1055/s-1980-29275
(1980)Doi:10.1002/ejoc.200400291
(2004)